Rebiotix and Ferring Announce World』s First With Positive Preliminary Pivotal Phase 3 Data for Investigational Microbiome-based Therapy RBX2660 ROSEVILLE, Minn. & SAINT-PREX, Switzerland — (BUSINESS WIRE) — Today, Rebiotix and Ferring Pharmaceuticals announced positive preliminary findings from their ongoing pivotal Phase 3 tr…